Abstract
Aim: Diagnosis for familial hypercholesterolemia (FH) relies on the identification of a causative pathogenic mutation. However, genetic testing is not widely available. We compared the validity of the three clinical diagnostic tools and their individual components in predicting an FH-causing mutation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have